Publication | Open Access

Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)

Liposomal Mtp-peEurosarc-memos TrialMalignant DiseaseMedicinePathologyCancer TreatmentOncologyRadiation OncologyMechanistic Biomarker Multi-arm